agilon health, inc. Restricted Cash and Cash Equivalents
agilon health, inc. (AGL) had Restricted Cash and Cash Equivalents of $564.48 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2022-11-03
- 2022-09-30: Restricted Cash and Cash Equivalents $564.48M.
- 2022-06-30: Restricted Cash and Cash Equivalents $683.66M.
- 2022-03-31: Restricted Cash and Cash Equivalents $1.04B.
- 2021-12-31: Restricted Cash and Cash Equivalents $1.05B.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2022-09-30 | $564.48M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $683.66M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.04B 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.05B 10-Q · filed 2022-11-03 |
| 2021-09-30 | $1.10B 10-Q · filed 2022-11-03 |
| 2021-06-30 | $1.13B 10-Q · filed 2022-08-04 |
| 2021-03-31 | $119.49M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $139.09M 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |